Michigan Senate Takes Action on Auto Insurance and Drug Laws

Michigan residents may soon have the ability to sue drug manufacturers and sellers for harm caused by FDA-approved pharmaceutical drugs, thanks to a bill passed by the Michigan Senate. For the past 28 years, Michigan has had immunity protections for pharmaceutical companies, preventing residents from seeking legal recourse or financial compensation. The bill, which received bipartisan support, aims to remove this immunity and allow residents to hold companies accountable. Michigan's strong corporate liability shield has resulted in the state missing out on potential payouts from major pharma litigation cases. However, it is unlikely that residents will be able to retroactively receive compensation for missed opportunities. The Michigan Chamber of Commerce opposes the bill, while pharmaceutical researchers argue that it would burden the industry with greater liability costs. The bill now moves to the Michigan House.